img

Global Alpha-1 Antitrypsin Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Alpha-1 Antitrypsin Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Alpha-1 Antitrypsin Drugs market is projected to reach US$ 2162.7 million in 2034, increasing from US$ 1217.6 million in 2022, with the CAGR of 8.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alpha-1 Antitrypsin Drugs market research.
Key manufacturers engaged in the Alpha-1 Antitrypsin Drugs industry include Baxter, CSL Behring, Grifols, Kamada, Abeona Therapeutics, Alnylam Pharmaceuticals, Applied Genetic Technologies Corp, Arrowhead Research Corporation and Baxalta, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Alpha-1 Antitrypsin Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Alpha-1 Antitrypsin Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alpha-1 Antitrypsin Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Segment by Type
Parenteral
Inhalation

Segment by Application


Drugstore
Hospital
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Alpha-1 Antitrypsin Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Alpha-1 Antitrypsin Drugs Market Overview
1.1 Product Overview and Scope of Alpha-1 Antitrypsin Drugs
1.2 Alpha-1 Antitrypsin Drugs Segment by Type
1.2.1 Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Alpha-1 Antitrypsin Drugs Segment by Application
1.3.1 Global Alpha-1 Antitrypsin Drugs Market Value by Application: (2024-2034)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Alpha-1 Antitrypsin Drugs Market Size Estimates and Forecasts
1.4.1 Global Alpha-1 Antitrypsin Drugs Revenue 2018-2034
1.4.2 Global Alpha-1 Antitrypsin Drugs Sales 2018-2034
1.4.3 Global Alpha-1 Antitrypsin Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Alpha-1 Antitrypsin Drugs Market Competition by Manufacturers
2.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Alpha-1 Antitrypsin Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Alpha-1 Antitrypsin Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Product Type & Application
2.7 Alpha-1 Antitrypsin Drugs Market Competitive Situation and Trends
2.7.1 Alpha-1 Antitrypsin Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue
2.7.3 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alpha-1 Antitrypsin Drugs Retrospective Market Scenario by Region
3.1 Global Alpha-1 Antitrypsin Drugs Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Alpha-1 Antitrypsin Drugs Global Alpha-1 Antitrypsin Drugs Sales by Region: 2018-2034
3.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2018-2024
3.2.2 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2024-2034
3.3 Global Alpha-1 Antitrypsin Drugs Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2018-2034
3.3.1 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2018-2024
3.3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2024-2034
3.4 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.4.1 North America Alpha-1 Antitrypsin Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Alpha-1 Antitrypsin Drugs Sales by Country (2018-2034)
3.4.3 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.5.1 Europe Alpha-1 Antitrypsin Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2018-2034)
3.5.3 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.7.1 Latin America Alpha-1 Antitrypsin Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2018-2034)
3.7.3 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2018-2034)
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2018-2024)
4.1.2 Global Alpha-1 Antitrypsin Drugs Sales by Type (2024-2034)
4.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2018-2034)
4.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2018-2034)
4.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2018-2024)
4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2024-2034)
4.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Alpha-1 Antitrypsin Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2018-2034)
5.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2018-2024)
5.1.2 Global Alpha-1 Antitrypsin Drugs Sales by Application (2024-2034)
5.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2018-2034)
5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2018-2034)
5.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2018-2024)
5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2024-2034)
5.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Alpha-1 Antitrypsin Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Kamada
6.4.1 Kamada Corporation Information
6.4.2 Kamada Description and Business Overview
6.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Kamada Alpha-1 Antitrypsin Drugs Product Portfolio
6.4.5 Kamada Recent Developments/Updates
6.5 Abeona Therapeutics
6.5.1 Abeona Therapeutics Corporation Information
6.5.2 Abeona Therapeutics Description and Business Overview
6.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio
6.5.5 Abeona Therapeutics Recent Developments/Updates
6.6 Alnylam Pharmaceuticals
6.6.1 Alnylam Pharmaceuticals Corporation Information
6.6.2 Alnylam Pharmaceuticals Description and Business Overview
6.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio
6.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.7 Applied Genetic Technologies Corp
6.6.1 Applied Genetic Technologies Corp Corporation Information
6.6.2 Applied Genetic Technologies Corp Description and Business Overview
6.6.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio
6.7.5 Applied Genetic Technologies Corp Recent Developments/Updates
6.8 Arrowhead Research Corporation
6.8.1 Arrowhead Research Corporation Corporation Information
6.8.2 Arrowhead Research Corporation Description and Business Overview
6.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio
6.8.5 Arrowhead Research Corporation Recent Developments/Updates
6.9 Baxalta
6.9.1 Baxalta Corporation Information
6.9.2 Baxalta Description and Business Overview
6.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio
6.9.5 Baxalta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
7.2 Alpha-1 Antitrypsin Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha-1 Antitrypsin Drugs Production Mode & Process
7.4 Alpha-1 Antitrypsin Drugs Sales and Marketing
7.4.1 Alpha-1 Antitrypsin Drugs Sales Channels
7.4.2 Alpha-1 Antitrypsin Drugs Distributors
7.5 Alpha-1 Antitrypsin Drugs Customers
8 Alpha-1 Antitrypsin Drugs Market Dynamics
8.1 Alpha-1 Antitrypsin Drugs Industry Trends
8.2 Alpha-1 Antitrypsin Drugs Market Drivers
8.3 Alpha-1 Antitrypsin Drugs Market Challenges
8.4 Alpha-1 Antitrypsin Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Alpha-1 Antitrypsin Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Alpha-1 Antitrypsin Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Alpha-1 Antitrypsin Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alpha-1 Antitrypsin Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Alpha-1 Antitrypsin Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Alpha-1 Antitrypsin Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Alpha-1 Antitrypsin Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Alpha-1 Antitrypsin Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Alpha-1 Antitrypsin Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Alpha-1 Antitrypsin Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Baxter Alpha-1 Antitrypsin Drugs Product
Table 74. Baxter Recent Developments/Updates
Table 75. CSL Behring Corporation Information
Table 76. CSL Behring Description and Business Overview
Table 77. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. CSL Behring Alpha-1 Antitrypsin Drugs Product
Table 79. CSL Behring Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Grifols Alpha-1 Antitrypsin Drugs Product
Table 84. Grifols Recent Developments/Updates
Table 85. Kamada Corporation Information
Table 86. Kamada Description and Business Overview
Table 87. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Kamada Alpha-1 Antitrypsin Drugs Product
Table 89. Kamada Recent Developments/Updates
Table 90. Abeona Therapeutics Corporation Information
Table 91. Abeona Therapeutics Description and Business Overview
Table 92. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product
Table 94. Abeona Therapeutics Recent Developments/Updates
Table 95. Alnylam Pharmaceuticals Corporation Information
Table 96. Alnylam Pharmaceuticals Description and Business Overview
Table 97. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product
Table 99. Alnylam Pharmaceuticals Recent Developments/Updates
Table 100. Applied Genetic Technologies Corp Corporation Information
Table 101. Applied Genetic Technologies Corp Description and Business Overview
Table 102. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product
Table 104. Applied Genetic Technologies Corp Recent Developments/Updates
Table 105. Arrowhead Research Corporation Corporation Information
Table 106. Arrowhead Research Corporation Description and Business Overview
Table 107. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product
Table 109. Arrowhead Research Corporation Recent Developments/Updates
Table 110. Baxalta Corporation Information
Table 111. Baxalta Description and Business Overview
Table 112. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Baxalta Alpha-1 Antitrypsin Drugs Product
Table 114. Baxalta Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Alpha-1 Antitrypsin Drugs Distributors List
Table 118. Alpha-1 Antitrypsin Drugs Customers List
Table 119. Alpha-1 Antitrypsin Drugs Market Trends
Table 120. Alpha-1 Antitrypsin Drugs Market Drivers
Table 121. Alpha-1 Antitrypsin Drugs Market Challenges
Table 122. Alpha-1 Antitrypsin Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alpha-1 Antitrypsin Drugs
Figure 2. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Alpha-1 Antitrypsin Drugs Market Share by Type in 2022 & 2034
Figure 4. Parenteral Product Picture
Figure 5. Inhalation Product Picture
Figure 6. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Alpha-1 Antitrypsin Drugs Market Share by Application in 2022 & 2034
Figure 8. Drugstore
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Alpha-1 Antitrypsin Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Alpha-1 Antitrypsin Drugs Market Size (2018-2034) & (US$ Million)
Figure 13. Global Alpha-1 Antitrypsin Drugs Sales (2018-2034) & (K Units)
Figure 14. Global Alpha-1 Antitrypsin Drugs Average Price (USD/Unit) & (2018-2034)
Figure 15. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 16. Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players: Market Share by Revenue in 2022
Figure 19. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Alpha-1 Antitrypsin Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2018-2034)
Figure 22. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2018-2034)
Figure 26. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2018-2034)
Figure 27. Germany Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2018-2034)
Figure 34. China Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2018-2034)
Figure 45. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Alpha-1 Antitrypsin Drugs by Type (2018-2034)
Figure 55. Global Revenue Market Share of Alpha-1 Antitrypsin Drugs by Type (2018-2034)
Figure 56. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Alpha-1 Antitrypsin Drugs by Application (2018-2034)
Figure 58. Global Revenue Market Share of Alpha-1 Antitrypsin Drugs by Application (2018-2034)
Figure 59. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2018-2034)
Figure 60. Alpha-1 Antitrypsin Drugs Value Chain
Figure 61. Alpha-1 Antitrypsin Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed